Potential of circulating tumor cells as blood-based biomarkers in cancer liquid biopsy

Pharmacogenomics. 2016 Feb;17(3):183-6. doi: 10.2217/pgs.15.163. Epub 2016 Jan 22.
No abstract available

Keywords: blood-based biomarkers; circulating tumor cells; liquid biopsy; personalized medicine; tumor heterogeneity.

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, Neoplasm / blood
  • Biomarkers, Tumor / blood*
  • Biomarkers, Tumor / genetics
  • Cell Adhesion Molecules / blood
  • Cell Separation
  • DNA, Neoplasm / blood
  • Epithelial Cell Adhesion Molecule
  • Epithelial-Mesenchymal Transition
  • Humans
  • Leukocyte Common Antigens / blood
  • Neoplasms / blood*
  • Neoplasms / diagnosis
  • Neoplasms / pathology
  • Neoplastic Cells, Circulating / metabolism
  • Neoplastic Cells, Circulating / pathology*
  • Precision Medicine

Substances

  • Antigens, Neoplasm
  • Biomarkers, Tumor
  • Cell Adhesion Molecules
  • DNA, Neoplasm
  • Epithelial Cell Adhesion Molecule
  • Leukocyte Common Antigens